oncology | Australian Doctor Group

Don't forget the 5-ARI factor in prostate testing

11th June 2019

Use of 5-alpha reductase inhibitors is associated with delayed diagnosis and higher mortality in men who develop prostate…

24th May 2019

Lenalidomide cuts the risk of smouldering multiple myeloma progressing to overt cancer, a randomised controlled phase II/III…

1st May 2019

Most teens and young adults with cancer want a voice in how their tumours are treated, but almost one in four express regret…

30th April 2019

A patient with a non-malignant bowel lesion who died after an unnecessary right hemicolectomy did not even realise the…

12th June 2019

This survey is produced and distributed by Australian Doctor Group on behalf of Leo Pharma. Australian Doctor wants to hear…

15th April 2019

One-third of cancer patients use complementary or alternative medicine (CAM) and about one in four fail to tell their…

9th April 2019

Patients with relapsed or refractory indolent non-Hodgkin lymphoma enjoy two years of progression-free survival when…

11th March 2019

Forty-one per cent of cancers detected by PSA screening can be classed as overdiagnosis, researchers say. Overdiagnosis of…